Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective

Journal of Thoracic and Cardiovascular Surgery

Volumn 146, Issue 1, 2013, Pages

  Doble, Brett ^a,b,c   Blackhouse, Gord ^a,b   Goeree, Ron ^a,b   Xie, Feng ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; CARDIAC IMPLANT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84879171204     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.06.018     Document Type: Article

References (55)

1. H. Baumgartner Aortic stenosis: medical and surgical management Heart 91 2005 1483 1488
2. R.O. Bonow, B.A. Carabello, C. Kanu, A.C. de Leon Jr., D.P. Faxon, and M.D. Freed ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Circulation 114 2006 e84 e231
3. J. Dunning, H. Gao, J. Chambers, N. Moat, G. Murphy, and D. Pagano Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use-an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database J Thorac Cardiovasc Surg 142 2011 776 782.e3
4. J.M. Brown, S.M. O'Brien, C. Wu, J.A. Sikora, B.P. Griffith, and J.S. Gammie Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database J Thorac Cardiovasc Surg 137 2009 82 90
5. M.B. Leon, C.R. Smith, M. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
6. J. Rodés-Cabau Transcatheter aortic valve implantation: current and future approaches Nat Rev Cardiol 9 2012 15 29
7. C.R. Smith, M.B. Leon, M.J. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
8. Human Mortality Database. Available at: www.mortality.org or www.humanmortality.de. Accessed November 25, 2011.
9. F. Aregger, P. Wenaweser, G.J. Hellige, A. Kadner, T. Carrel, and S. Windecker Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement Nephrol Dial Transplant 24 2009 2175 2179
10. OCCI Costing Analysis Tool. 2010. Available at: http://www.occp.com. Accessed November 4, 2011.
11. M. McGregor, and S. Esfandiari Transcatheter Aortic Valve Implantation (TAVI) at MUHC: A Health Technology Assessment, Report Number 45 2009 Technology Assessment Unit of the McGill University Health Centre Montreal, Canada
12. A. Cavallo, M. Cerbo, T. Jefferson, A. Lo Scalzo, A. Migliore, and M. Ratti Transapical Transcatheter Aortic Valve Implantation 2009 Agenzia Nazionale per i Servizi Sanitari Regionali (Agenas) Rome, Italy
13. S.T. Brady, C.A. Davis, W.G. Kussmaul, W.K. Laskey, J.W. Hirshfeld Jr., and H.C. Herrmann Percutaneous aortic balloon valvuloplasty in octogenarians: morbidity and mortality Ann Intern Med 110 1989 761 766
14. Ontario Drug Benefit Formulary/Comparative Drug Index. 2010. Available at: http://www.health.gov.on.ca/english/providers/program/drugs/odbf-eformulary. html. Accessed November 5, 2011.
15. J. Rodes-Cabau, J.G. Webb, A. Cheung, J. Ye, E. Dumont, and C.M. Feindel Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience J Am Coll Cardiol 55 2010 1080 1090
16. W.R. Jamieson, P.C. Cartier, M. Allard, C. Boutin, I.G. Burwash, and J. Butany Surgical management of valvular heart disease 2004 Can J Cardiol 20 Suppl E 2004 7E 120E
17. P.S. Wells, H. Majeed, S. Kassem, N. Langlois, B. Gin, and J. Clermont A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: derivation in a sample with predominantly a history of venous thromboembolism Thromb Res 125 2010 e259 e264
18. H. Krum The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005) Eur Heart J 26 2005 2472.
19. A. Gohler, B.P. Geisler, J.M. Manne, M. Kosiborod, Z. Zhang, and W.S. Weintraub Utility estimates for decision-analytic modeling in chronic heart failure-health states based on New York Heart Association classes and number of rehospitalizations Value Health 12 2009 185 187
20. A.H. Briggs, R. Goeree, G. Blackhouse, and B.J. O'Brien Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease Med Decis Making 22 2002 290 308
21. M. Neyt, H. Van Brabandt, and S. Van de Sande Transcatheter Aortic Valve Implantation (TAVI): A Health Technology Assessment Update KCE reports 163C 2011 Belgian Health Care Knowledge Centre (KCE) Brussels, Belgium
22. M. Watt, S. Mealing, J. Eaton, N. Piazza, N. Moat, and P. Brasseur Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement Heart 98 2012 370 376
23. C. Tamburino, D. Capodanno, A. Ramondo, A.S. Petronio, F. Ettori, and G. Santoro Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis Circulation 123 2011 299 308
24. M. Thomas, G. Schymik, T. Walther, D. Himbert, T. Lefevre, and H. Treede One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve Circulation 124 2011 425 433
25. R. Goeree, and L. Levin Building bridges between academic research and policy formulation: the PRUFE framework - an integral part of Ontario's evidence-based HTPA process Pharmacoeconomics 24 2006 1143 1156
26. H. Bronnum-Hansen, M. Davidsen, and P. Thorvaldsen Long-term survival and causes of death after stroke Stroke 32 2001 2131 2136
27. G.A. Wellenius, and M.A. Mittleman Disparities in myocardial infarction case fatality rates among the elderly: the 20-year Medicare experience Am Heart J 156 2008 483 490
28. K. Akposso, A. Hertig, R. Couprie, A. Flahaut, C. Alberti, and G.A. Karras Acute renal failure in patients over 80 years old: 25-years' experience Intensive Care Med 26 2000 400 406
29. M. Thielmann, D. Wendt, H. Eggebrecht, P. Kahlert, P. Massoudy, and M. Kamler Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement Ann Thorac Surg 88 2009 1468 1474
30. S.T. Brady, C.A. Davis, W.G. Kussmaul, W.K. Laskey, J.W. Hirshfeld Jr., and H.C. Herrmann Percutaneous aortic balloon valvuloplasty in octogenarians: morbidity and mortality Ann Intern Med 110 1989 761 766
31. S. Omer, D. Chu, J. Huh, J.S. Coselli, S.A. Lemaire, and S. Sansgiry Outcomes of aortic valve replacement performed by residents in octogenarians J Surg Res 156 2009 139 144
32. M.B. Leon, C.R. Smith, M. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
33. C.R. Smith, M.B. Leon, M.J. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
34. A. Cristian, K. Mandy, and B. Root Comparison between men and women admitted to an inpatient rehabilitation unit after cardiac surgery Arch Phys Med Rehabil 80 1999 183 185
35. S.C. Malaisrie, P.M. McCarthy, E.C. McGee, R. Lee, V.H. Rigolin, and C.J. Davidson Contemporary perioperative results of isolated aortic valve replacement for aortic stenosis Ann Thorac Surg 89 2010 751 756
36. M.J. Hollander, and N.L. Chappell A comparative analysis of costs to government for home care and long-term residential care services, standardized for client care needs Can J Aging 26 Suppl S1 2007 149 161
37. OCCI Costing Analysis Tool. 2010. Available at: http://www.occp.com. Accessed November 4, 2011.
38. R. Goeree, G. Blackhouse, R. Petrovic, and S. Salama Cost of stroke in Canada: a 1-year prospective study J Med Econ 8 2005 147 167
39. B. Manns, C.J. Doig, H. Lee, S. Dean, M. Tonelli, and D. Johnson Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery Crit Care Med 31 2003 449 455
40. A. Terent, L.A. Marke, K. Asplund, B. Norrving, E. Jonsson, and P.O. Wester Costs of stroke in Sweden. A national perspective Stroke 25 1994 2363 2369
41. N. Frasure-Smith, F. Lesperance, G. Gravel, A. Masson, M. Juneau, and M. Talajic Depression and health-care costs during the first year following myocardial infarction J Psychosom Res 48 2000 471 478
42. J.M. Lightwood, and S.A. Glantz Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke Circulation 96 1997 1089 1096
43. A. Gohler, B.P. Geisler, J.M. Manne, M. Kosiborod, Z. Zhang, and W.S. Weintraub Utility estimates for decision-analytic modeling in chronic heart failure-health states based on New York Heart Association classes and number of rehospitalizations Value Health 12 2009 185 187
44. A.B. Rosen, V.G. Fowler Jr., G.R. Corey, S.M. Downs, A.K. Biddle, and J. Li Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia Ann Intern Med 130 1999 810 820
45. P.A. Heidenreich, F.A. Masoudi, B. Maini, T.M. Chou, E. Foster, and N.B. Schiller Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis Am J Med 107 1999 198 208
46. D.J. Cohen, J.A. Breall, K.K. Ho, R.E. Kuntz, L. Goldman, and D.S. Baim Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model Circulation 89 1994 1859 1874
47. C.R. Mitton, M.S. Rose, M.L. Koshman, and R.S. Sheldon Cost-utility analysis of pacemakers for the treatment of vasovagal syncope Am J Cardiol 84 1999 1356 1359 A8
48. G. Salkeld, P. Phongsavan, B. Oldenburg, M. Johannesson, P. Convery, and P. Graham-Clarke The cost-effectiveness of a cardiovascular risk reduction program in general practice Health Policy 41 1997 105 119
49. M.H. Eckman, H.J. Levine, D.N. Salem, and S.G. Pauker Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues Chest 114 5 Suppl 1998 699S 714S
50. M.H. Eckman, R.H. Falk, and S.G. Pauker Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation Arch Intern Med 158 1998 1669 1677
51. B.F. Gage, A.B. Cardinalli, G.W. Albers, and D.K. Owens Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation JAMA 274 1995 1839 1845
52. N.A. Solomon, H.A. Glick, C.J. Russo, J. Lee, and K.A. Schulman Patient preferences for stroke outcomes Stroke 25 1994 1721 1725
53. R. Zeckhauser, and D. Shepard Where now for saving lives? Law Contemp Probl 40 1976 5 45
54. M.B. Hamel, R.S. Phillips, R.B. Davis, N. Desbiens, A.F. Connors Jr., and J.M. Teno Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments Ann Intern Med 127 1997 195 202
55. G.A. de Wit, P.G. Ramsteijn, and F.T. de Charro Economic evaluation of end stage renal disease treatment Health Policy 44 1998 215 232